Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Cash from Discontinued Operations (2016 - 2017)

Nutex Health's Cash from Discontinued Operations history spans 5 years, with the latest figure at 8655.0 for Q4 2017.

  • For Q4 2017, Cash from Discontinued Operations rose 15.47% year-over-year to 8655.0; the TTM value through Mar 2019 reached 8655.0, down 3491.29%, while the annual FY2017 figure was 9216.0, 93.03% up from the prior year.
  • Cash from Discontinued Operations for Q4 2017 was 8655.0 at Nutex Health, down from 819.0 in the prior quarter.
  • Across five years, Cash from Discontinued Operations topped out at 618246.0 in Q2 2014 and bottomed at 269436.0 in Q1 2016.
  • The 4-year median for Cash from Discontinued Operations is 819.0 (2017), against an average of 64745.23.
  • The largest annual shift saw Cash from Discontinued Operations soared 6282.74% in 2015 before it crashed 103.06% in 2016.
  • A 4-year view of Cash from Discontinued Operations shows it stood at 5417.0 in 2014, then skyrocketed by 6282.74% to 334919.0 in 2015, then plummeted by 103.06% to 10239.0 in 2016, then rose by 15.47% to 8655.0 in 2017.
  • Per Business Quant, the three most recent readings for NUTX's Cash from Discontinued Operations are 8655.0 (Q4 2017), 819.0 (Q3 2017), and 9233.0 (Q2 2017).